Press release
Lewy Body Dementia Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends
Lewy Body Dementia Market
The growing prevalence of brain-related disorders is expected to boost the growth of the Lewy body dementia (LBD) market in the future. Brain-related disorders encompass various conditions that affect the brain's structure and function, leading to cognitive decline, memory loss, and behavioral changes. The prevalence of brain-related disorders is rising due to factors such as aging, genetic predisposition, and environmental factors. The increasing prevalence of these disorders increases the demand for improved treatments and early detection for Lewy body dementia, which, in turn, stimulates research, funding, and innovation, leading to faster advancements in diagnosis and therapy for LBD. For example, in October 2023, the World Federation of Neurology, a UK-based association, stated that over 40% of the global population suffers from neurological conditions, with this burden expected to nearly double by 2050. Therefore, the rising prevalence of brain-related disorders will drive the growth of the Lewy body dementia market."
Get Your Lewy Body Dementia Market Report Here:
https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-global-market-report
What growth opportunities are expected to drive the lewy body dementia market's CAGR through 2034?
The Lewy body dementia market has grown strongly, increasing from $1.12 billion in 2024 to $1.21 billion in 2025 at a CAGR of 7.5%. The expansion is due to a growing aging population, increased awareness of neurodegenerative diseases, rising healthcare expenditures, improved diagnostic criteria, and regulatory approvals for dementia drugs.
The Lewy body dementia market is anticipated to grow significantly, with its value reaching $1.60 billion by 2029 at a CAGR of 7.2%. The primary factors driving this growth include an increasing prevalence of dementia, rising investment in research and development, heightened demand for early diagnostic solutions, expanding adoption of telemedicine, and a stronger focus on personalized treatment. Key trends in this sector include the development of targeted therapies, the expansion of clinical trials, advancements in diagnostic technologies, technological innovations, and a growing emphasis on novel therapeutic approaches.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21213&type=smp
What are the emerging trends shaping the future of the lewy body dementia market?
In the Lewy Body Dementia (LBD) market, companies are investing heavily in research to develop more effective neurodegenerative treatments. Research investment helps uncover new insights, enhance therapeutic solutions, and improve patient outcomes. For instance, in March 2023, the National Institute on Aging awarded $21 million to support drug development research for LBD. Researchers at the University of Miami Miller School of Medicine initiated a Phase 2b study of neflamapimod, a drug showing promising results in earlier trials, aiming to address the unmet needs of LBD patients.
Which growth-oriented segments of the lewy body dementia market are leading the industry's development?
The lewy body dementia market covered in this report is segmented -
1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis
2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications
3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users
Subsegments:
1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment
2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI), Genetic Biomarkers, Blood-Based Biomarkers
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21213
What regions are leading the charge in the lewy body dementia market?
North America was the largest region in the lewy body dementia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the lewy body dementia market?
Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21213&type=smp
What Is Covered In The Lewy Body Dementia Global Market Report?
•Market Size Forecast: Examine the lewy body dementia market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the lewy body dementia market for a structured understanding.
•Key Players Overview: Analyze major players in the lewy body dementia market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the lewy body dementia market.
•Segment Contributions: Evaluate how different segments drive overall growth in the lewy body dementia market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the lewy body dementia market.
•Industry Challenges: Identify potential risks and obstacles affecting the lewy body dementia market.
•Competitive Landscape: Review strategic developments in the lewy body dementia market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lewy Body Dementia Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here
News-ID: 3934720 • Views: …
More Releases from The Business Research Company
What Is Driving Global Kidney Dialysis Market Growth in 2025: The Role of Growin …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Kidney Dialysis Market Size Growth Forecast: What to Expect by 2025?
Considerable upward momentum has been observed in the renal dialysis sector's valuation recently; specifically, it is projected to expand from $85.65 billion in the year 2024 to reach $90.88 billion by 2025, reflecting a compound annual growth rate…
Comprehensive Idiopathic Pulmonary Fibrosis Market Forecast 2025-2034: Growth Tr …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Idiopathic Pulmonary Fibrosis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market valuation for idiopathic pulmonary fibrosis has shown robust expansion recently, moving from a figure of $4.15 billion in 2024 to an anticipated $4.37 billion by 2025, which reflects a steady compound annual…
The Rise In The Prevalence Of Skin Diseases : Powering Innovation and Expansion …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Hidradenitis Suppurativa Market Through 2025?
Recent years have witnessed robust expansion within the hidradenitis suppurativa market, which is projected to increase its valuation from $1.16 billion in 2024 to $1.24 billion the following year, reflecting a compound annual growth rate (CAGR) of…
2025-2034 Health Economics and Outcomes Research (HEOR) Services Market Outlook: …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Health Economics and Outcomes Research (HEOR) Services Industry Market Size Be by 2025?
The market encompassing health economics and outcomes research (HEOR) services has experienced swift expansion recently, projecting an increase from $1.57 billion in 2024 to $1.76 billion the following year, reflecting a compound annual…
More Releases for Lewy
Lewy Body Dementia Treatment Market Trends That Will Shape the Next Decade: Insi …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Lewy Body Dementia Treatment Market Size By 2025?
The market for lewy body dementia therapies has experienced robust expansion lately, projected to increase its valuation from $4.43 billion in 2024 to $4.69 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.8%; this…
Lewy Body Dementia Market to Reach USD 9.4 Billion by 2034
Lewy Body Dementia (LBD) is the second most common form of progressive dementia after Alzheimer's disease, accounting for 10-15% of dementia cases. It is caused by the abnormal accumulation of alpha-synuclein protein (Lewy bodies) in the brain, leading to cognitive decline, visual hallucinations, fluctuating alertness, REM sleep behavior disorder, and Parkinsonism symptoms.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71909
With aging populations and rising awareness, the LBD market is…
Lewy Body Dementia Market Forecast 2025-2034: Comprehensive Analysis And Growth …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Lewy Body Dementia Market?
In recent times, the market size for Lewy body dementia has witnessed substantial growth. It is projected to increase from $1.12 billion in 2024 to $1.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The historic growth…
Lewy Body Disease Pipeline: 10+ Innovators Advancing Disease-Modifying and Sympt …
Lewy Body Disease (LBD), including dementia with Lewy bodies and Parkinson's disease dementia, is a complex neurodegenerative condition attracting the attention of over 10 key companies such as Cognition Therapeutics, Eli Lilly and Company, Athira Pharma, and NLS Pharmaceutics. The LBD pipeline features therapies targeting alpha-synuclein, neuroprotective agents, and symptomatic treatments that address cognition, motor symptoms, and neuropsychiatric complications. With no approved disease-modifying treatment, this pipeline represents a vital frontier…
Lewy Body Dementia Treatment Market Challenges: Growth, Share, Value, Trends and …
Lewy Body Dementia Treatment Market Size And Forecast by 2031
The LBD Therapy Market is expanding rapidly, driven by increasing consumer demand, technological advancements, and industry-wide innovation. According to top market research firms, businesses in the Neurodegenerative Disorder Treatment Market are prioritizing digital transformation, product development, and data-driven decision-making to stay competitive. With rising investments in automation and efficiency, the Dementia Care Market is evolving to meet changing customer preferences.…
Lewy Body Dementia Treatment Market Focuses on Advancements in Diagnosis and The …
Global Lewy Body Dementia Treatment Market, By Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Antidepressants, Benzodiazepine, and Modafinil), Application Type (Parkinson's Disease and Alzheimer's Disease), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies and Others) - Industry Trends and Forecast to 2031.
Data Bridge Market Research analyses that the Global Lewy Body Dementia Treatment Market which was USD 5.66 Billion in 2023…
